We are live on !
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter Est. Return
+29.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$56.9M
Cap. Flow % of AUM
Cap. Flow %
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JOYY Inc
JOYY
|
+$3.5M |
| 2 |
Weibo
WB
|
+$2.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.76M |
| 4 |
Hesai Group
HSAI
|
+$1.67M |
| 5 |
Structure Therapeutics
GPCR
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$23.4M |
| 2 |
Yum China
YUMC
|
+$14M |
| 3 |
TSMC
TSM
|
+$8.84M |
| 4 |
Pinduoduo
PDD
|
+$8.79M |
| 5 |
Apple
AAPL
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Linde
LIN
$230B
| $315K | 0.02% |
766
+4
| +0.5% | +$1.58K |
2021 Q1
11 quarters
|
|
227
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $314K | 0.02% |
+10,888
| New | +$259K |
2023 Q4
0 quarters
|
|
228
BioCryst Pharmaceuticals
BCRX
$1.99B
| $307K | 0.02% |
51,317
+9,820
| +24% | +$56.9K |
2021 Q1
11 quarters
|
|
229
Dollar Tree
DLTR
$23.3B
| $307K | 0.02% |
2,158
-245
| -10% | -$29K |
2021 Q1
11 quarters
|
|
230
Rhythm Pharmaceuticals
RYTM
$5.93B
| $300K | 0.02% |
+6,533
| New | +$206K |
2023 Q4
0 quarters
|
|
231
Medtronic
MDT
$121B
| $298K | 0.02% |
3,617
+434
| +14% | +$33.1K |
2021 Q1
11 quarters
|
|
232
Zentalis Pharmaceuticals
ZNTL
$202M
| $293K | 0.02% |
19,340
+9,033
| +88% | +$132K |
2022 Q1
7 quarters
|
|
233
Elevance Health
ELV
$92.9B
| $292K | 0.02% |
620
+55
| +10% | +$25.4K |
2021 Q1
11 quarters
|
|
234
CVS Health
CVS
$118B
| $289K | 0.02% |
3,658
+313
| +9% | +$22.3K |
2021 Q1
11 quarters
|
|
235
Bristol-Myers Squibb
BMY
$122B
| $288K | 0.02% |
5,619
+902
| +19% | +$47.3K |
2021 Q1
11 quarters
|
|
236
Stryker
SYK
$113B
| $287K | 0.02% |
957
+124
| +15% | +$34.8K |
2021 Q1
11 quarters
|
|
237
GlobalFoundries
GFS
$26B
| $286K | 0.02% |
4,714
-453
| -9% | -$25.1K |
2022 Q4
4 quarters
|
|
238
Cigna
CI
$79.9B
| $285K | 0.02% |
953
+176
| +23% | +$51.4K |
2021 Q1
11 quarters
|
|
239
DELISTED
SpringWorks Therapeutics
SWTX
| $283K | 0.02% |
7,752
-1,474
| -16% | -$38.5K |
2022 Q1
7 quarters
|
|
240
Zscaler
ZS
$33.8B
| $283K | 0.02% |
1,277
-100
| -7% | -$18.5K |
2023 Q3
1 quarter
|
|
241
Wells Fargo
WFC
$252B
| $282K | 0.02% |
5,731
+21
| +0.4% | +$906 |
2021 Q1
11 quarters
|
|
242
Zoetis
ZTS
$32.8B
| $277K | 0.02% |
1,403
+207
| +17% | +$36.6K |
2021 Q1
11 quarters
|
|
243
Diamondback Energy
FANG
$57.1B
| $277K | 0.02% |
1,783
-184
| -9% | -$28.8K |
2022 Q4
4 quarters
|
|
244
Trade Desk
TTD
$5.78B
| $276K | 0.02% |
3,841
-368
| -9% | -$27K |
2023 Q3
1 quarter
|
|
245
DELISTED
Warner Bros
WBD
| $273K | 0.02% |
23,983
-2,472
| -9% | -$26.7K |
2022 Q4
4 quarters
|
|
246
DELISTED
89bio
ETNB
| $272K | 0.02% |
24,363
+4,742
| +24% | +$43.6K |
2023 Q1
3 quarters
|
|
247
Take-Two Interactive
TTWO
$38.4B
| $270K | 0.02% |
+1,678
| New | +$250K |
2023 Q4
0 quarters
|
|
248
Boston Scientific
BSX
$64.3B
| $266K | 0.02% |
4,607
+683
| +17% | +$36.5K |
2021 Q3
9 quarters
|
|
249
Las Vegas Sands
LVS
$24.6B
| $263K | 0.02% |
+5,345
| New | +$253K |
2023 Q4
0 quarters
|
|
250
Coca-Cola Europacific Partners
CCEP
$49.4B
| $262K | 0.02% |
+3,932
| New | +$240K |
2023 Q4
0 quarters
|
|
Similar funds
E Fund Management's Q4 2023 Portfolio in Review
As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.
Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.
- E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
- E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
- E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
- E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
- E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
- E Fund Management opened 38 new positions and closed 24 in Q4 2023.
- E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.
Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.